No takes yet. Share an insight, caveat, or question.
Review highlights the oncogenic role of stearoyl-CoA desaturase 1 across various cancers, suggesting SCD1 inhibition is a viable therapeutic strategy against aggressive tumors.
Tracz‐Gaszewska et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: